These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10360744)

  • 1. Substituted piperidines--highly potent renin inhibitors due to induced fit adaptation of the active site.
    Vieira E; Binggeli A; Breu V; Bur D; Fischli W; Güller R; Hirth G; Märki HP; Müller M; Oefner C; Scalone M; Stadler H; Wilhelm M; Wostl W
    Bioorg Med Chem Lett; 1999 May; 9(10):1397-402. PubMed ID: 10360744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?
    Oefner C; Binggeli A; Breu V; Bur D; Clozel JP; D'Arcy A; Dorn A; Fischli W; Grüninger F; Güller R; Hirth G; Märki H; Mathews S; M ller M; Ridley RG; Stadler H; Vieira E; Wilhelm M; Winkler F; Wostl W
    Chem Biol; 1999 Mar; 6(3):127-31. PubMed ID: 10074464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperidine-renin inhibitors compounds with improved physicochemical properties.
    Güller R; Binggeli A; Breu V; Bur D; Fischli W; Hirth G; Jenny C; Kansy M; Montavon F; Müller M; Oefner C; Stadler H; Vieira E; Wilhelm M; Wostl W; Märki HP
    Bioorg Med Chem Lett; 1999 May; 9(10):1403-8. PubMed ID: 10360745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and discovery of new (3S,5R)-5-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]piperidine-3-carboxamides as potent renin inhibitors.
    Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Sugita C; Miyazaki S; Tamaki K; Matsui Y; Takahashi M; Nagayama T; Nagai Y; Inoue S; Nishi T
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7677-82. PubMed ID: 23122821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel class of oral direct renin inhibitors: highly potent 3,5-disubstituted piperidines bearing a tricyclic p3-p1 pharmacophore.
    Ostermann N; Ruedisser S; Ehrhardt C; Breitenstein W; Marzinzik A; Jacoby E; Vangrevelinghe E; Ottl J; Klumpp M; Hartwieg JC; Cumin F; Hassiepen U; Trappe J; Sedrani R; Geisse S; Gerhartz B; Richert P; Francotte E; Wagner T; Krömer M; Kosaka T; Webb RL; Rigel DF; Maibaum J; Baeschlin DK
    J Med Chem; 2013 Mar; 56(6):2196-206. PubMed ID: 23360239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitors.
    Cody WL; Holsworth DD; Powell NA; Jalaie M; Zhang E; Wang W; Samas B; Bryant J; Ostroski R; Ryan MJ; Edmunds JJ
    Bioorg Med Chem; 2005 Jan; 13(1):59-68. PubMed ID: 15582452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperidine-based renin inhibitors: upper chain optimization.
    Corminboeuf O; Bezençon O; Remeň L; Grisostomi C; Richard-Bildstein S; Bur D; Prade L; Strickner P; Hess P; Fischli W; Steiner B; Treiber A
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6291-6. PubMed ID: 20843690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and optimization of new piperidines as renin inhibitors.
    Corminboeuf O; Bezençon O; Grisostomi C; Remeň L; Richard-Bildstein S; Bur D; Prade L; Hess P; Strickner P; Fischli W; Steiner B; Treiber A
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6286-90. PubMed ID: 20843686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile.
    Tokuhara H; Imaeda Y; Fukase Y; Iwanaga K; Taya N; Watanabe K; Kanagawa R; Matsuda K; Kajimoto Y; Kusumoto K; Kondo M; Snell G; Behnke CA; Kuroita T
    Bioorg Med Chem; 2018 Jul; 26(12):3261-3286. PubMed ID: 29754833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct renin inhibitors as a new therapy for hypertension.
    Webb RL; Schiering N; Sedrani R; Maibaum J
    J Med Chem; 2010 Nov; 53(21):7490-520. PubMed ID: 20731374
    [No Abstract]   [Full Text] [Related]  

  • 11. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of spirocyclic piperidines.
    Chen A; Aspiotis R; Campeau LC; Cauchon E; Chefson A; Ducharme Y; Falgueyret JP; Gagné S; Han Y; Houle R; Laliberté S; Larouche G; Lévesque JF; McKay D; Percival D
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7399-404. PubMed ID: 22071301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines.
    Chen A; Campeau LC; Cauchon E; Chefson A; Ducharme Y; Dubé D; Falgueyret JP; Fournier PA; Gagné S; Grimm E; Han Y; Houle R; Huang JQ; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; McKay D; Percival MD; Regan C; Regan H; St-Jacques R; Toulmond S
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3970-5. PubMed ID: 21621998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,4-Diarylpiperidines as potent renin inhibitors.
    Lacombe P; Arbour M; Aspiotis R; Cauchon E; Chen A; Dubé D; Falgueyret JP; Fournier PA; Gallant M; Grimm E; Han Y; Juteau H; Liu S; Mellon C; Ramtohul Y; Simard D; St-Jacques R; Tsui GC
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1953-7. PubMed ID: 22325946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery and synthesis of potent zwitterionic inhibitors of renin.
    Aspiotis R; Chen A; Cauchon E; Dubé D; Falgueyret JP; Gagné S; Gallant M; Grimm EL; Houle R; Juteau H; Lacombe P; Laliberté S; Lévesque JF; MacDonald D; McKay D; Percival MD; Roy P; Soisson SM; Wu T
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2430-6. PubMed ID: 21429746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents.
    Lévesque JF; Bleasby K; Chefson A; Chen A; Dubé D; Ducharme Y; Fournier PA; Gagné S; Gallant M; Grimm E; Hafey M; Han Y; Houle R; Lacombe P; Laliberté S; MacDonald D; Mackay B; Papp R; Tschirret-Guth R
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5547-51. PubMed ID: 21784634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of a new series of N-(piperidin-3-yl)pyrimidine-5-carboxamides as renin inhibitors.
    Imaeda Y; Tawada M; Suzuki S; Tomimoto M; Kondo M; Tarui N; Sanada T; Kanagawa R; Snell G; Behnke CA; Kubo K; Kuroita T
    Bioorg Med Chem; 2016 Nov; 24(22):5771-5780. PubMed ID: 27687967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors.
    Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Fujimoto T; Sugita C; Miyazaki S; Tamaki K; Nagayama T; Nagai Y; Inoue S; Chiba K; Nishi T
    Bioorg Med Chem; 2013 Sep; 21(18):5907-22. PubMed ID: 23886807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow, tight binding to human renin of some nonpeptidic renin inhibitors containing a 4-methoxymethoxypiperidinylamide at the P4 position.
    Stein HH; Fung AK; Cohen J; Baker WR; Rosenberg SH; Boyd SA; Dayton BD; Armiger YL; Condon SL; Mantei RA
    FEBS Lett; 1992 Apr; 300(3):301-4. PubMed ID: 1555659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperidine renin inhibitors: from leads to drug candidates.
    Märki HP; Binggeli A; Bittner B; Bohner-Lang V; Breu V; Bur D; Coassolo PH; Clozel JP; D'Arcy A; Doebeli H; Fischli W; Funk CH; Foricher J; Giller T; Grüninger F; Guenzi A; Güller R; Hartung T; Hirth G; Jenny CH; Kansy M; Klinkhammer U; Lave T; Lohri B; Luft FC; Mervaala EM; Müller DN; Müller M; Montavon F; Oefner CH; Qiu C; Reichel A; Sanwald-Ducray P; Scalone M; Schleimer M; Schmid R; Stadler H; Treiber A; Valdenaire O; Vieira E; Waldmeier P; Wiegand-Chou R; Wilhelm M; Wostl W; Zell M; Zell R
    Farmaco; 2001; 56(1-2):21-7. PubMed ID: 11347960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. trans-3,4-dimethyl-4-(3-carboxamidophenyl)piperidines: a novel class of micro-selective opioid antagonists.
    Le Bourdonnec B; Belanger S; Cassel JA; Stabley GJ; DeHaven RN; Dolle RE
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4459-62. PubMed ID: 14643346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.